Evolus (EOLS) EBT Margin (2019 - 2026)
Evolus (EOLS) posted EBT Margin of -9.76% for Q2 2026, up 14.87 percentage points from -24.63% a year earlier and up 4.49 percentage points from the prior quarter.
Powered by 
Analysis
Evolus (EOLS) EBT Margin (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBT Margin at Evolus was -10.64%, up 11.41 percentage points year-over-year; for FY2025, it was -17.15%, up 1.54 percentage points from FY2024.
- Annual EBT Margin has increased for three consecutive years, with a five-year change of +271.03 percentage points (FY2020 to FY2025).
- In prior years, Evolus' EBT Margin was -18.69% in FY2024 (+11.75 pp), -30.44% in FY2023 (+19.57 pp), -50.01% in FY2022 (-3.08 pp) and -46.92% in FY2021 (+241.26 pp).
- Quarterly EBT Margin has run from a low of -72.80% in Q3 2021 to a high of 0.57% in Q4 2025 over five years.
- On a year-over-year basis, EBT Margin has increased in each of the last four quarters, with an average year-over-year change of +5.74 percentage points over the last eight quarters.
- The strongest year-over-year quarter for EBT Margin in the past five years was Q4 2021, with a gain of 486.26 percentage points; the weakest was Q1 2022, with a drop of 104.01 percentage points.
- According to Business Quant data, EBT Margin for the three prior quarters was -14.24% (Q1 2026), 0.57% (Q4 2025) and -22.58% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 41.75% |
| 10 | Evolus | 527.45 Mn | 335.14 Mn | 57.18 Mn | -9.76% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.76% |
| Mar 31, 2026 | -14.24% |
| Dec 31, 2025 | 0.57% |
| Sep 30, 2025 | -22.58% |
| Jun 30, 2025 | -24.63% |
| Mar 31, 2025 | -27.47% |
| Dec 31, 2024 | -8.04% |
| Sep 30, 2024 | -31.16% |
| Jun 30, 2024 | -16.90% |
| Mar 31, 2024 | -22.01% |
| Dec 31, 2023 | -19.22% |
| Sep 30, 2023 | -33.79% |
| Jun 30, 2023 | -36.71% |
| Mar 31, 2023 | -35.40% |
| Dec 31, 2022 | -30.03% |
| Sep 30, 2022 | -59.78% |
| Jun 30, 2022 | -63.08% |
| Mar 31, 2022 | -51.62% |
| Dec 31, 2021 | -52.42% |
| Sep 30, 2021 | -72.80% |
API Access
Evolus EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=EOLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "EOLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=EOLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();